Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 459-465

  Connop, B P ^a   Boegman, R J ^a   Beninger, R J ^a   Jhamandas, K ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

7 nitro indazole (7 NI); excitotoxicity; malonate; N( ) nitro L arginine methyl ester (L NAME); nitric oxide synthase (NOS); Parkinson's disease

Indexed keywords

7 NITROINDAZOLE; DIZOCILPINE; MALONIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN PROTECTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; MALE; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0029896430     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00194-8     Document Type: Article

References (47)

1. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42: 733-738.
2. Albin R. L., Makowiec R. L., Hollingsworth Z. R., Dure IV L. S., Penney J. B., and Young A. B. (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46: 35-48.
3. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31: 119-130.
4. Beal M. F. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? TINS 16: 125-131.
5. Beal M. F., Brouillet E., Jenkins B., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R. and Hyman B. T. (1993a) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13: 4181-4192.
6. Beal M. F., Brouillet E., Jenkins B., Henshaw R., Rosen B. and Hyman B. T. (1993b) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61: 1147-1150.
7. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. natn. Acad. Sci. U.S.A. 87: 1620-1624.
8. Bloem B. R., Irwin L, Buruma O. J. S., Haan J., Roos R. A. C., Tetrud J. W. and Langston J. W. (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J. Neurol. Sci. 97: 273-293.
9. Bolaños J. P., Peuchen S., Heales S. J. R., Land J. M. and Clark J. B. (1994) Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63: 910-916.
10. Bradford M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72: 248.
11. Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. natn. Acad. Sci. U.S.A. 87: 682-685.
12. Brune B. and Lapetina E. (1989) Activation of cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. biol. Chem. 264: 8455-8458.
13. Christoffersen C. L. and Meltzer L. T. (1995) Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for the N-methyl-D-aspartate receptors. Neuroscience 67: 373-381.
14. Connop B. P., Rolfe N. G., Boegman R. J., Jhamandas K. and Beninger R. J. (1994) Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole Neuropharmacology 33: 1439-1445.
15. Connop B. P., Boegman R. J., Jhamandas K. and Beninger R. J. (1995) Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res. 676: 124-132.
16. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. natn. Acad. Sci. U.S.A. 88: 6368-6371.
17. Demerle-Pallardy C., Lonchampt M., Chabrier P. and Braquet P. (1991) Absence of implication of L-arginine/nitric oxide pathway on neuronal cell injury induced by L-glutamate or hypoxia. Biochem. biophys. Res. Commun. 181: 456-464.
18. Dexter D. T., Sian J., Rose S., Hindmarsh J. G., Mann V. M., Cooper J. M., Wells F. R., Daniel S. E., Lees A. J., Schapira A. H. V., Jenner P. and Marsden C. D. (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy Body disease. Ann. Neurol 35: 38-44.
19. Difazio M. C., Hollingsworth Z., Young A. B. and Penney J. B. (1992) Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42: 402-406.
20. Dirnagl U., Lindauer U. and Villringer A. (1993) Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci. Lett. 149: 43-46.
21. Faraci F. M. and Breese K. R. (1994) Nitric oxide mediates vasodilation in response to activation of AT-methyl-D-aspartate receptors in brain. Circ. Res. 72: 476-480.
22. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. TINS 14: 61-67.
23. Gluck M. R., Krueger M. J., Ramsey R. R., Sabin S. O., Singer T. P. and Nicklas W. J. (1994) Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparation. J. Biol. Chem. 269: 3167-3174.
24. Greene J. G. and Greenamyre J. T. (1995a) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64: 430-436.
25. Greene J. G. and Greenamyre J. T. (1995b) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J. Neurochem. 64: 2332-2338.
26. Greene J. G., Porter R. H. P., Eller R. V. and Greenamyre J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61: 1151-1154.
27. Henshaw R., Jenkins B. G. Schulz J. B., Ferrante R. J., Kowall N. W., Rosen B. R. and Beal M. F. (1994) Malonate produces striatal lesions by indirect NMDA receptor activation. Brain Res. 647: 161-166.
28. Iadecola C. (1993) Regulation of cerebral microcirculation during neural activity: is nitric oxide the missing link? TINS 16: 206-214.
29. Johnson M. D. and Ma P. M. (1993) Localization of NADPH diaphorase activity in monoaminergic neurons of the rat brain. J. Comp. Neurol. 332: 391-496.
30. Kikuchi S. and Kim S. U. (1993) Glutamate neurotoxicity on mesencephalic neurons in culture. J. Neurosci. Res. 36: 558-569.
31. MacKenzie G. M., Rose S., Bland-Ward P. A., Moore P. K., Jenner P. and Marsden C. D. (1994) Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport 5: 1993-1996.
32. Maragos W. F. and Silverstein F. S. (1995) Inhibition of nitric oxide synthase activity attenuates dopaminergic striatal malonate lesions in rats. J. Neurochem. 64: 2362-2365.
33. Novelli A., Reilly J. A., Lysko P. G. and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451: 205-212.
34. Paxinos G. and Watson C. (1982) In The Rat Brain in Stereotaxic Coordinates (2nd Edition). Academic Press, Toronto.
35. +) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J. Neurochem. 56: 1184-1190.
36. Rigaud A. S., Pinard E., Charbonne R., Heron A. and Seylaz J. (1993) Crucial role of NO in the increase in cerebral blood flow during seizures. J. cereb. Blood Flow Metab. 13: suppl. S167.
37. Saporito M. S., Heikkila R. E., Youngster S. K., Nicklas W. J. and Geller H. M. (1991) Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration. J. Pharmacol. exp. Ther. 260: 1400-1409.
38. Schapira A. H. V. (1994) Evidence for mitochondrial dysfunction in Parkinson's disease - a critical appraisal. Movement Dis. 9: 125-138.
39. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E. and Beal M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64: 936-939.
40. Sonsalla P. K., Zeevalk G. D., Manzino L., Giovanni A., and Nicklas W. J. (1992) MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem. 58: 1979-1982.
41. Storey B., Hyman B. T., Jenkins B., Brouillet E., Miller J. M., Rosen B. R. and Beal M. F. (1992) 1-methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58: 1975-1978.
42. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414-418.
43. Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46: 755-784.
44. Vrana S. L., Azzaro A. J. and Vrana K. E. (1992) Chronic selegiline administration transiently decrease tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway. Molec. Pharm. 41: 839-844.
45. Yamauchi T. and Fujisawa H. (1978) A simple and sensitive fluorometric assay for tyrosine hydroxylase. Analyt. Biochem. 89: 143-150.
46. Zeevalk G. D., Derr-Yellin E. and Nicklas W. J. (1995) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64: 455-458.
47. Zeevalk G. D. and Nicklas W. J. (1990) Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. exp. Ther. 253: 1285-1292.